Scanogen is a molecular diagnostic company.
Scanogen has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Scanogen's investors include National Institute of Allergy and Infectious Diseases.
Scanogen is headquartered in Windsor Mill, United States.
Scanogen is a molecular diagnostic company.
Scanogen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scanogen — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/scanogen. Accessed October 6, 2026.
VCBacked. (2025). Scanogen — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/scanogen
{{cite web |title=Scanogen — Funding & Investors |url=https://www.vcbacked.co/company/scanogen |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated